Tag: Pharmaceutical Industry

Pharmaceutical Sector has Worst Reputation Among All US Industries

New research has found that the pharmaceutical industry now has the worst reputation according to Americans, compared to all industries. The lost of 25 sectors that Gallup reviews every year found ...

Personalized medicine will have the biggest impact on pharma industry in 2019

According to the report, ‘The State of the Biopharmaceutical Industry - 2019’, 31% of global industry respondents believe that immuno-oncology will have the greatest impact on the pharma sector.

MMCC aims to catalyze transformational Change in Microbiology Testing

Attending Pharmig 2018, AstraZeneca's Karen Capper and GSK's Paul J Newby unveiled details of the Microbiology Modernisation Cross-industry Consortium (MMCC), an initiative that has been in the making...

India and Cuba aimed to enhance cooperation in biotech and pharma industries

India and Cuba identified new sectors for bilateral cooperation during the recent Havana International Fair, one of the most representative business events in Latin America and the Caribbean.

India and Turkmenistan expanding pharmaceutical partnership

A meeting with an Indian delegation consisting of heads and representatives of about 30 pharmaceutical companies was held at the Union of Industrialists and Entrepreneurs of Turkmenistan. The Union...

Indian pharma manufacturers had a meeting with Russian colleagues

The event was initiated by the Council for promoting the development of export by Indian pharma manufacturers with support from the Ministry of Commerce and Industry of the Government of India.

Pharma market penetration of Russian drugs rose in the 1st half of 2018

Russian drugs penetration into the pharmaceutical market rose in the 1st half of 2018. This was presented to the participants of "Pharma CFO 2018" by Raziya Solodova.

Data integrity was discussed at the ‘Pharmtech & Ingredients’ exhibition

On 20 November, at the exhibition "Pharmtech & Ingredients", held in Crocus Expo (Moscow), the panel discussion on the topic "Data integrity management: key aspects" was organized.

Immuno-oncology became the current drug development trend

According to the new report from GlobalData, a leading data and analytics company, Immuno-Oncology (IO) development is booming with IO agents being investigated in most cancer types.

St. Petersburg hosts 8th annual forum “Life Sciences Invest. Partnering Russia”

life sciences forum
The VIII annual international partnering-forum "Life Sciences Invest. Partnering Russia" started in St. Petersburg. The first day of the Forum brought together nearly 650 people. The key discussion...

SID&GP signs a cooperation agreement with PharmaPharm

The State Institute of Drugs and Good Practices signed a cooperation agreement with the integrated pharmaceutical portal PharmaPharm within the framework of Life Sciences Invest in St. Petersburg.

SID&GP representatives participated in workshop on pharma industry automation

Representatives of the State Institute of Drugs and Good Practices took part in the workshop dedicated to automation of the pharmaceutical industry organized by the Ministry of Industry and Trade.

AbbVie presses charges against UK National Health Service

abbvie office
Abbvie, a global pharmaceutical company, is claiming that National Health Service (UK) breached procurement rules during a process seeking suppliers for hepatitis C treatment.

Japanese pharma industry energized by the next wave of growth

Japan’s pharmaceutical industry is the third largest worldwide after the US and China with a share of approximately ten percent of the world market and a value expected to reach $109 billion by 2026.

Russian pharma companies to receive government subsidies

Such a support measure is implemented within the state program of the Russian Federation "Development of the pharmaceutical and medical industry" for 2013-2020.

The Director of FSI ‘SID & GP’ participated in the XI Eurasian Economic Forum

The Director of the Russian Federal State-funded Institution “State Institute of Drugs and Good Practices”, Vladislav Shestakov, took part in the XI Eurasian Economic Forum.